daunorubicin has been researched along with Lymphoma, B-Cell, Marginal Zone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Attarbaschi, A; Burkhardt, B; Kabickova, E; Klapper, W; Makarova, O; Müller, S; Niggli, F; Oschlies, I; Ruf, S; Woessmann, W; Zimmermann, M | 1 |
1 other study(ies) available for daunorubicin and Lymphoma, B-Cell, Marginal Zone
| Article | Year |
|---|---|
Excellent outcome with limited treatment in paediatric patients with marginal zone lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Neoplasm Staging; Prednisone; Treatment Outcome; Vincristine | 2018 |